The Intersection Of Biotechnology And Pharmacogenomics: Health Policy Implications
Author:
Affiliation:
1. University of California, San Francisco
Publisher
Health Affairs (Project Hope)
Subject
Health Policy
Reference18 articles.
1. A vision for the future of genomics research
2. As biotech turns 20...
3. As biotech turns 20...
4. Biopharmaceuticals: recent approvals and likely directions
5. Prospective care: a personalized, preventative approach to medicine
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stakeholders’ views on the value of outcomes from clinical genetic and genomic interventions;Genetics in Medicine;2019-06
2. Review of core-multishell nanostructured models for nano-biomedical and nano-biopharmaceutical application;Bio-Medical Materials and Engineering;2018-09-17
3. R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014;BioMed Research International;2017
4. Cancer patients’ acceptance, understanding, and willingness-to-pay for pharmacogenomic testing;Pharmacogenetics and Genomics;2014-07
5. Overcoming regulatory and economic challenges facing pharmacogenomics;New Biotechnology;2012-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3